| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone methyltransferase binding | 2.09e-04 | 18 | 24 | 2 | GO:1990226 | |
| Domain | Zinc_finger_PHD-type_CS | 2.88e-03 | 65 | 23 | 2 | IPR019786 | |
| Domain | PHD | 3.81e-03 | 75 | 23 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 4.22e-03 | 79 | 23 | 2 | IPR019787 | |
| Domain | PHD | 5.32e-03 | 89 | 23 | 2 | SM00249 | |
| Domain | Znf_PHD | 5.56e-03 | 91 | 23 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 6.04e-03 | 95 | 23 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 6.17e-03 | 96 | 23 | 2 | PS01359 | |
| Domain | SH2 | 6.80e-03 | 101 | 23 | 2 | PF00017 | |
| Domain | SH2 | 8.02e-03 | 110 | 23 | 2 | SM00252 | |
| Domain | SH2 | 8.16e-03 | 111 | 23 | 2 | PS50001 | |
| Domain | SH2 | 8.31e-03 | 112 | 23 | 2 | IPR000980 | |
| Domain | - | 8.31e-03 | 112 | 23 | 2 | 3.30.505.10 | |
| Domain | Znf_FYVE_PHD | 1.40e-02 | 147 | 23 | 2 | IPR011011 | |
| Domain | - | 1.71e-02 | 449 | 23 | 3 | 3.30.40.10 | |
| Domain | SH3_1 | 1.72e-02 | 164 | 23 | 2 | PF00018 | |
| Domain | Znf_RING/FYVE/PHD | 1.81e-02 | 459 | 23 | 3 | IPR013083 | |
| Pubmed | Reciprocal regulation of C-Maf tyrosine phosphorylation by Tec and Ptpn22. | 1.49e-06 | 3 | 25 | 2 | 25993510 | |
| Pubmed | Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. | 1.39e-05 | 8 | 25 | 2 | 19264985 | |
| Pubmed | 1.11e-04 | 130 | 25 | 3 | 12421765 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.37e-04 | 430 | 25 | 4 | 35044719 | |
| Pubmed | 2.74e-04 | 34 | 25 | 2 | 20494980 | ||
| Pubmed | 3.00e-04 | 847 | 25 | 5 | 35850772 | ||
| Pubmed | 4.61e-04 | 44 | 25 | 2 | 26471122 | ||
| Pubmed | Large-scale structural analysis of the classical human protein tyrosine phosphatome. | 5.26e-04 | 47 | 25 | 2 | 19167335 | |
| Pubmed | 6.05e-04 | 551 | 25 | 4 | 34728620 | ||
| GeneFamily | PHD finger proteins | 2.81e-03 | 90 | 16 | 2 | 88 | |
| GeneFamily | SH2 domain containing | 3.52e-03 | 101 | 16 | 2 | 741 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.40e-02 | 206 | 16 | 2 | 682 | |
| Coexpression | GSE7460_TREG_VS_TCONV_ACT_DN | 2.45e-05 | 197 | 23 | 4 | M5691 | |
| Coexpression | GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_UP | 2.60e-05 | 200 | 23 | 4 | M5985 | |
| Coexpression | GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_DN | 2.60e-05 | 200 | 23 | 4 | M6949 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.94e-05 | 128 | 25 | 3 | c2045f052cc713e52312eb015825711576fcb6c5 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-05 | 129 | 25 | 3 | cbeeaa554da971ba2e4c4b82c85a1d070a45abb8 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells-iNKT-MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.66e-05 | 134 | 25 | 3 | 92981dc68c1b3cdc53f9cf83386c47f0c6c98ae7 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Mast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.73e-05 | 142 | 25 | 3 | f7d0d5ca9fc3dd929d4fdd59b71bfa623007e992 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Mast-Mast_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.73e-05 | 142 | 25 | 3 | 2a9a070e7c53ac593d46c6c5f6983f07d4413501 | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT-T-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.61e-05 | 148 | 25 | 3 | 003e10bf477984248211b99d75daa8f7dcdb12c8 | |
| ToppCell | Control-Lymphocytic_NKT-T_cells-iNKT-MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.07e-05 | 151 | 25 | 3 | 7e5e35ce601ca3d3722063566e89664909171b8d | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.58e-05 | 160 | 25 | 3 | 6d941e584360975e1fdbb2fc67af8e31f18759d8 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-04 | 165 | 25 | 3 | 62457b7b74c6eae42d91d65e7dc6df6bf8e061f7 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-04 | 174 | 25 | 3 | 33386750842c47ad7e7286d0f26a556da1a2de02 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-regulatory_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-04 | 174 | 25 | 3 | 9344d4e76d7d9429aea87d3c0b98246200d16014 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-04 | 176 | 25 | 3 | 6b1cf1e98b4509e87f9eea827fa7090ce1e504f1 | |
| ToppCell | Severe-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.31e-04 | 178 | 25 | 3 | b7374a97c51239782bed658381a02cb1b3d9bf66 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.38e-04 | 181 | 25 | 3 | 986c036e656f24fe374807e2711cec9e3c83c892 | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-04 | 183 | 25 | 3 | 59e8d07556390828f7557ba3fd2f7d49851498b7 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 183 | 25 | 3 | ffb1bbbccb34d1a7e99872611f497450039d5019 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 184 | 25 | 3 | a6dee97ee4ef9d89e11d17339e0dadaea1210ce5 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 184 | 25 | 3 | e6bf826be31e1723e24c366fc5a1cee9b15589bc | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.47e-04 | 185 | 25 | 3 | f1263899a2d41d182022dc4ca62cbae08a463c89 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.50e-04 | 186 | 25 | 3 | bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe | |
| Drug | silaned | 1.14e-07 | 43 | 24 | 4 | CID006335299 | |
| Drug | X-GlcA | 2.97e-05 | 8 | 24 | 2 | CID002733578 | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; HL60; HT_HG-U133A | 4.56e-05 | 192 | 24 | 4 | 3046_DN | |
| Drug | di-n-butyl sebacate | 4.77e-05 | 10 | 24 | 2 | CID000007986 | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; PC3; HT_HG-U133A | 4.85e-05 | 195 | 24 | 4 | 6761_UP | |
| Drug | Protoveratrine A [143-57-7]; Up 200; 5uM; MCF7; HT_HG-U133A | 4.95e-05 | 196 | 24 | 4 | 4963_UP | |
| Drug | Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; PC3; HT_HG-U133A | 5.04e-05 | 197 | 24 | 4 | 2072_DN | |
| Drug | Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; PC3; HT_HG-U133A | 5.04e-05 | 197 | 24 | 4 | 4315_UP | |
| Drug | Methacholine chloride [62-51-1]; Up 200; 20.4uM; PC3; HT_HG-U133A | 5.04e-05 | 197 | 24 | 4 | 5773_UP | |
| Drug | Sulfamethizole [144-82-1]; Up 200; 14.8uM; PC3; HT_HG-U133A | 5.04e-05 | 197 | 24 | 4 | 5798_UP | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 5.04e-05 | 197 | 24 | 4 | 6449_UP | |
| Drug | Sulfamerazine [127-79-7]; Up 200; 15.2uM; PC3; HT_HG-U133A | 5.25e-05 | 199 | 24 | 4 | 3718_UP | |
| Drug | S010 | 6.98e-05 | 12 | 24 | 2 | CID006452892 | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 1.85e-07 | 170 | 23 | 5 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | tyrosine-protein kinase TEC measurement | 3.48e-06 | 4 | 23 | 2 | EFO_0020830 | |
| Disease | myositis | 3.71e-06 | 39 | 23 | 3 | EFO_0000783 | |
| Disease | rheumatoid arthritis | 2.45e-05 | 462 | 23 | 5 | EFO_0000685 | |
| Disease | Genetic chronic primary adrenal insufficiency | 4.51e-05 | 13 | 23 | 2 | Orphanet_101960 | |
| Disease | cystathionine measurement | 9.86e-05 | 19 | 23 | 2 | EFO_0010474 | |
| Disease | Prostatic Neoplasms | 1.21e-03 | 616 | 23 | 4 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.21e-03 | 616 | 23 | 4 | C0376358 | |
| Disease | cigarettes per day measurement | 4.61e-03 | 438 | 23 | 3 | EFO_0006525 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VKIPEETEEPIRPRP | 416 | P58335 | |
| RAEEPRPQEPPVETP | 351 | O43918 | |
| AAIPERVEEIPPEVP | 161 | O95072 | |
| RVEEIPPEVPTEPRE | 166 | O95072 | |
| TEPREPERIPVTVLP | 176 | O95072 | |
| PVPRLIITPETPEPE | 326 | Q96DU7 | |
| APRIDDEIPPPLPVR | 606 | Q9Y2R2 | |
| PVREPERYPLPTVLP | 141 | A6NJV1 | |
| EPSEPVPPLIVDRER | 1386 | Q9ULI0 | |
| EAIPEPVVRILPPLE | 96 | Q9NQC1 | |
| EEPLIVPEVRRPPEP | 556 | P98095 | |
| RERDEEQEPPPLLPP | 21 | Q9Y5B6 | |
| VVPVPERPPEPRAMD | 1341 | A7KAX9 | |
| PPPLPPRLREEAEEQ | 146 | Q8N9I9 | |
| VEERDPPRRVPPPAL | 1321 | Q14152 | |
| EEDEPEIPLSPRPRP | 746 | Q13698 | |
| EEEVRRELALPPPDP | 176 | Q8NHY3 | |
| PPRRREPEEPAAPEV | 46 | A4D1U4 | |
| VEPQPQPEPTPVREE | 36 | O14556 | |
| PPPEITRRPVEDLIL | 696 | Q8IY37 | |
| PRPPRPAETKVPEEI | 361 | Q5VZR2 | |
| ELLPPELPPRIPIEE | 466 | Q9NRF2 | |
| EEERPKPSRPVVPPL | 36 | P13805 | |
| RRPPPPIPLEEEDNS | 166 | P42680 | |
| LEEVRQPPPRVRPVP | 1561 | O95785 | |
| EVRIGDRDPIPLPVP | 131 | Q9H7N4 | |
| RSVPQPEPEPEPERE | 241 | Q9P2Y4 |